Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Couturaud, C. Leroyer, J. Julian, S. Kahn, J. Ginsberg, P. Wells, J. Douketis, D. Mottier, C. Kearon (Brest, France; Hamilton, Montreal, Ottawa, Canada). Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM). Eur Respir J 2008; 32: Suppl. 52, 1043

Member's Comments

No comment yet.

Related content which might interest you: The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL) Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003 PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001 The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020 Higher plasma total homocysteine (tHcy) level and abnormal methionine loading test (MLT) in family members of patients with pulmonary embolism (PE) and carriers of factor V Leiden (FVL) Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002 Age is a major risk factor of venous thromboembolism (VTE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 The acquired and inherited risk factors in venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A Source: Eur Respir J 2003; 22: Suppl. 45, 443s Year: 2003 Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006 Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003 Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza Source: Eur Respir J 2010; 36: 1346-1354 Year: 2010 Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)? Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE) Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019